Nutreco invests in ViAqua to combat disease in the shrimp market
Nutreco has announced an investment in Israeli startup ViAqua as part of its focus on combatting disease in the aquaculture industry. ViAqua is developing the first orally-administered treatment for shrimp that improves resistance to viral diseases, including White Spot Syndrome Virus (WSSV), and prevents viral epidemics.
Continue this article…
Already subscribed? SIGN IN now
Register for a FREE one-month trial to continue this article
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:
- Weekly newsletters providing valuable news and information on the commercial fishing and aquaculture sector
- Full access to our news archive
- Live and archived webinars, podcasts and videos
- Articles on innovations and current trends in the commercial fishing industry
- Our extensive archive of data, research and intelligence
Get more free content sign up today
Ready to subscribe? Choose from one of our subscription packages for unlimited access!
